Harvey Partners’s Rentokil RTO Stock Holding History
Bought
Maintained
Sold
Other funds holding RTO
JT
GCM
RRAM
SCM
SL
Harvey Partners's RTO Position: Q2 2026 in Review
Harvey Partners increased its Rentokil (RTO) stake by 0.87% in Q2 2026, buying an estimated $268K and bringing the position to 983,956 shares worth $28.2M. The position accounts for 1.93% of the portfolio, ranked #24.
Harvey Partners first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $41.2M in Q4 2024. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.
- Harvey Partners held 983,956 shares of Rentokil worth $28.2M as of Q2 2026.
- Harvey Partners bought 8,456 Rentokil shares in Q2 2026, an estimated $268K.
- Rentokil made up 1.93% of Harvey Partners's portfolio in Q2 2026, its #24 holding.
- Harvey Partners first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
- Harvey Partners's Rentokil position peaked at $41.2M in Q4 2024.
- 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.
Based on Harvey Partners's 13F filing for Q2 2026, filed 14 Aug 2026.